Ramon I. Klein Geltink

Author

Max Planck Institute of Immunobiology and Epigenetics ORCID

Also Known As

Ju Hee Oh, R Klein Geltink, R Klein-Geltink, R. I. Klein Geltink, R. Klein Geltink, Ramon I Klein Geltink, Ramon I. Klein Geltink, Ramon I. Klein-Geltink, Ramon Klein Geltink, Ramon Klein-Geltink

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Max Planck Institute of Immunobiology and Epigenetics University of Freiburg University of British Columbia University Medical Center Freiburg BC Children's Hospital

About

Ramon I. Klein Geltink is an author at Max Planck Institute of Immunobiology and Epigenetics specializing in medicine, cell biology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	2.1K
2	Biochemistry	2	2	150
3	Engineering	1	1	78
4	Health Sciences	1	1	17
5	Natural Sciences	1	1	48

Ramon I. Klein Geltink

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming Michael D. Buck, David O’Sullivan, Ramon I. Klein Geltink, Cell Mitochondrial FunctionMitochondrial DynamicMetabolic ProgrammingMitochondrial DynamicsMetabolism	2016	1.4K
Polyamines and eIF5A Hypusination Modulate Mitochondrial Respiration and Macrophage Activation Daniel J. Puleston, Michael D. Buck, Ramon I. Klein Geltink, Cell Metabolism	2019	381
Acetate Promotes T Cell Effector Function during Glucose Restriction Jing Qiu, Matteo Villa, David E. Sanin, Cell Reports	2019	319
Triacylglycerol synthesis enhances macrophage inflammatory function Ângela Castoldi, Lauar de Brito Monteiro, Nikki van Teijlingen Bakker, Nature Communications	2020	278
Mitochondrial Priming by CD28 Ramon I. Klein Geltink, David O’Sullivan, Mauro Corrado, Cell Mitochondrial BiogenesisMitochondrial FunctionMolecular BiologyMitochondrial PrimingMedicine	2017	274
Metabolic conditioning of CD8+ effector T cells for adoptive cell therapy Ramon I. Klein Geltink, Joy Edwards-Hicks, Petya Apostolova, Nature Metabolism Cell TherapyAdaptive Immune SystemT-regulatory CellImmunologyAutoimmunity	2020	131
ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer Franklin C. Harwood, Ramon I. Klein Geltink, Brendan P. O’Hara, Science Advances	2018	130
Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma Haifeng Zhang, Christopher S. Hughes, Wei Li, Cancer Discovery	2021	104
Mitochondrial Membrane Potential Regulates Nuclear Gene Expression in Macrophages Exposed to Prostaglandin E2 David E. Sanin, Mai Matsushita, Ramon I. Klein Geltink, Immunity InflammationReductive StressMitophagyProstaglandin E2Signal Transduction	2018	102
MN1 overexpression is an important step in the development of inv(16) AML Cintia Carella, Jacqueline Bonten, Tanya A. Kranenburg, Leukemia Mn1 OverexpressionImportant StepEngineeringMolecular Biology	2007	78

Page 1